West Pharma (WST) Tops Q1 EPS by 26c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall St slumps as sharp tech losses put Nasdaq on course for correction
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $406.91 -0.46%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q1 EPS of $1.56, $0.26 better than the analyst estimate of $1.30. Revenue for the quarter came in at $695.4 million versus the consensus estimate of $670.31 million.
GUIDANCE:
West Pharma sees FY2024 EPS of $7.63-$7.88, versus the consensus of $7.63. West Pharma sees FY2024 revenue of $3-3.025 billion, versus the consensus of $3.011 billion.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- Ralph Lauren (RL) Tops Q2 EPS by 41c
- Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 12c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
